News & Resources
Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.
-
How FDA’s Guidance on Decentralized Trials Applies to Community-based Research Execution and Compliance
In September 2024, the U.S. Food and Drug Administration (FDA) issued its final guidance titled Conducting Clinical Trials with Decentralized Elements. The document outlines how decentralized trial components—particularly mobile visits conducted in participants’ homes, mobile research sites, and local community health facilities—can be implemented in a compliant, regulated framework. The guidance […]
-
Virtually tour our dedicated research sites within Prime Healthcare
In the summer of 2024, EmVenio launched brick-and-mortar clinical trial research centers on select Prime hospital campuses. Like our mobile community research sites, these locations were strategically chosen using social determinants of health of the surrounding community. The sites reach new patient demographics that are statistically underrepresented in clinical trials, […]
-
Understanding Social Determinants of Health and Why They Matter in Clinical Research
Clinical research has traditionally focused almost entirely on study eligibility, but as the push for more inclusive research continues to grow, it has become increasingly apparent that eligibility alone is not sufficient. To truly expand access and improve representation in trials, sponsors must also consider the broader context of participant […]
-
Why sponsors should be using community research in obesity and diabetes trials
As activity explodes in the obesity field, it’s the perfect time to address patient population challenges in the metabolic disease therapy area. Here’s why patient-centric strategies such as mobile research or community sites could be key to increasing patient recruitment and retention. The World Health Organization has called obesity “one […]
-
Where Precision Meets Personal Connection: Robert Lohayza’s Role as a CMRN
Meet Robert Lohayza, a Certified Mobile Research Nurse (CMRN) at PCM Trials. Mobile clinicians play a vital role in supporting participant optionality in clinical trials by traveling to participants anytime, anywhere to conduct mobile visits. In this interview, Robert shares how his autonomy, adaptability, and passion for connection have shaped his nursing […]
-
The next stage of DCTs: New survey sheds light on how to move forward with mobile visits
Mobile research adoption is set to continue growing in clinical trials, but what challenges and concerns does this pose for researchers, and how can the industry overcome these barriers in order to get a major step closer to patient-centric clinical trials? Mobile research models are making a positive difference in […]
-
Why mobile nurse visits have a place in clinical trials, according to industry survey
In the first article of a two-part series, we examine recent survey findings to understand the role that mobile visits are playing in clinical trials. Clinical trials are on the move, with an increasing number of sponsors exploring ways to bring their studies closer to local communities and the potential […]
-
Why you should include SDOH in clinical trial recruitment
Housing, health literacy, transportation and social support are all aspects that contribute to clinical trial effectiveness in addition to standard clinical care. How can the industry better incorporate social determinants of health (SDOH) into clinical studies to increase patient recruitment and retention? Diversity in clinical trials is not merely a […]
-
Diversity data in the US: Understanding the FDA’s push for more representation in clinical trials
While diversity has been an important topic in the clinical trial industry for many years, new guidance from the FDA has put the focus on action for 2025 and beyond. Diversity in clinical trials has been the focus of numerous industry discussions in recent years. This is for good reason, […]
-
Intravenous Infusions in Decentralized Clinical Trials
Intravenous infusions are becoming increasingly common in DCTs, but administering these treatments is not without its challenges. This whitepaper explores the rising need for remote intravenous infusions in trials, the key considerations when administering these types of therapies in a DCT context, and the importance of highly trained mobile research […]
-
Designing trials for greater reach and retention with community-based research
In this discussion, team members from PCM Trials and EmVenio Research, a PCM Trials company, explore recent FDA guidance on diversity and share how community-based research models improve accessibility to help achieve diversity benchmarks in clinical trials. Learn how mobile visits and community sites deliver patient-centric solutions to remove barriers […]
-
Building Your Toolkit: How to Operationalize FDA Guidance on Diversity
In this discussion, team members from PCM Trials and EmVenio Research, a PCM Trials company, explore recent FDA guidance on diversity and share how community-based research models improve accessibility to help achieve diversity benchmarks in clinical trials. Learn how mobile visits and community sites deliver patient-centric solutions to remove barriers […]
